We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Investors' focus is likely to be on GILD???s HIV franchise performance and oncology sales when the company reports ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.21% of ...

Bullish option flow detected in Gilead (GILD) with 4,231 calls trading, 1.7x expected, and implied vol increasing almost 2 points to 28.65%.

For the first time, the Asia Pacific Chemsex Symposium (APCS) has moved from Taipei to Bangkok, marking a new chapter in its ...

Creative Financial Designs Inc. ADV boosted its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.4% during the third quarter, HoldingsChannel.com reports. The institutional investor ...

Morgan Stanley analyst Terence Flynn maintained a Hold rating on C4 Therapeutics (CCCC – Research Report) today and set a price target of ...

Professor Angela, Leung Yee-man, Associate Head (Research) of the School of Nursing at The Hong Kong Polytechnic University; ...

However we still have some important companies with Palantir (PLTR), Super Micro computer (SMCI), Block (SQ), Moderna (MRNA), Qualcomm (QCOM), Arista Networks (ANET), Gilead Sciences (GILD) and Airbnb ...

AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...

As election week jitters markets, Reddit celebrates its first-ever profit while an under-the-radar Aussie company shines.

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...